Skip to main content

Table 2 Physiological results from volume regulated perfusion

From: Diazoxide protects against doxorubicin-induced cardiotoxicity in the rat

  DIADOX DIA5HDDOX 5HDDOX DIASAL 5HDSAL SALSAL SALDOX
LVDP (mmHg) 141.5 ± 6.9* 127.9 ± 4.3 108.1 ± 9.3 149.5 ± 10.8* 155.6 ± 13.0* 162.9 ± 14.7* 117.1 ± 9.1
LVEDP (mmHg) 9.6 ± 2.5* 16.0 ± 2.2 15.8 ± 2.1 10.6 ± 1.8* 8.2 ± 1.0* 9.3 ± 1.6* 18.0 ± 13.2
AoP (mmHg) 103.9 ± 2.2* 124.2 ± 5.1 130.5 ± 7.3 82.7 ± 6.0* 76.0 ± 3.5* 76.9 ± 3.6* 133.7 ± 5.0
Heart rate (beats per minute) 300 ± 0 300 ± 0 300 ± 0 300 ± 0 300 ± 0 300 ± 0 300 ± 0
dp/dtmax (mmHg/s) 3697.4 ± 141.0* 2512.9 ± 302.0 2950.7 ± 237.5 4583.6 ± 546.9* 3935.7 ± 213.6* 3973.6 ± 246.9* 2777.8 ± 386.9
dp/dtmin (mmHg/s) −2380.6 ± 157.0 −2176.4 ± 154.8 −2530.1 ± 251.4 −2940.8 ± 261.6 −3041.6 ± 403.1 2862.0 ± 295.1 −2579.8 ± 329.1
Coronary flow (ml/min) 12.5 ± 0 12.5 ± 0 12.5 ± 0 12.5 ± 0 12.5 ± 0 12.5 ± 0 12.5 ± 0
  1. Values presented as mean ± standard deviation (SD). *Significantly different from hearts in SALDOX, p < 0.05.